• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型隐球菌刺激单核细胞释放白细胞介素-15后可诱导抗菌活性。

Interleukin-15 induces antimicrobial activity after release by Cryptococcus neoformans-stimulated monocytes.

作者信息

Mody C H, Spurrell J C, Wood C J

机构信息

Department of Internal Medicine, University of Calgary, Alberta, Canada.

出版信息

J Infect Dis. 1998 Sep;178(3):803-14. doi: 10.1086/515381.

DOI:10.1086/515381
PMID:9728550
Abstract

A newly described cytokine, interleukin (IL)-15, shares many activities with IL-2; however, little is known about the stimuli for release of IL-15, and its role in antimicrobial host defense has not previously been demonstrated. This study found that Cryptococcus neoformans is a potent stimulus for the release of biologically active IL-15 from monocytes. Both IL-15 and IL-2 made significant contributions to lymphocyte proliferation and lymphocyte-mediated anticryptococcal activity to encapsulated and acapsular C. neoformans. IL-15 restored lymphocyte proliferation and anticryptococcal activity that had been abrogated by blocking IL-2. IL-15 also enhanced the anticryptococcal activity of lymphocytes but did not enhance the activity of monocytes. This suggests that IL-15 and IL-2 cooperate for lymphocyte activation and proliferation in vitro and demonstrates that IL-15 can induce antimicrobial activity. Taken together, these data suggest that microbes, and in particular C. neoformans, are an important stimulus for IL-15 and that IL-15 may have an important role in induction of antimicrobial effector mechanisms.

摘要

一种新发现的细胞因子——白细胞介素(IL)-15,与IL-2具有许多共同活性;然而,对于IL-15释放的刺激因素知之甚少,并且其在抗微生物宿主防御中的作用此前尚未得到证实。本研究发现,新型隐球菌是单核细胞释放生物活性IL-15的有效刺激物。IL-15和IL-2对淋巴细胞增殖以及淋巴细胞介导的针对包膜和无包膜新型隐球菌的抗隐球菌活性均有显著贡献。IL-15恢复了因阻断IL-2而被消除的淋巴细胞增殖和抗隐球菌活性。IL-15还增强了淋巴细胞的抗隐球菌活性,但未增强单核细胞的活性。这表明IL-15和IL-2在体外协同促进淋巴细胞的激活和增殖,并证明IL-15可诱导抗微生物活性。综上所述,这些数据表明微生物,尤其是新型隐球菌,是IL-15的重要刺激物,并且IL-15可能在诱导抗微生物效应机制中发挥重要作用。

相似文献

1
Interleukin-15 induces antimicrobial activity after release by Cryptococcus neoformans-stimulated monocytes.新型隐球菌刺激单核细胞释放白细胞介素-15后可诱导抗菌活性。
J Infect Dis. 1998 Sep;178(3):803-14. doi: 10.1086/515381.
2
Specific activated T cells regulate IL-12 production by human monocytes stimulated with Cryptococcus neoformans.特定活化的T细胞调节经新型隐球菌刺激的人单核细胞产生白细胞介素-12。
J Immunol. 1999 Feb 1;162(3):1618-23.
3
Mechanisms by Which Interleukin-12 Corrects Defective NK Cell Anticryptococcal Activity in HIV-Infected Patients.白细胞介素-12纠正HIV感染患者自然杀伤细胞抗隐球菌活性缺陷的机制。
mBio. 2016 Aug 23;7(4):e00878-16. doi: 10.1128/mBio.00878-16.
4
The effect of infection with human immunodeficiency virus on the anticryptococcal activity of lymphocytes and monocytes.
J Infect Dis. 1995 Sep;172(3):665-71. doi: 10.1093/infdis/172.3.665.
5
Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.白细胞介素-10与白细胞介素-12在调节T细胞分化及单核细胞对新型隐球菌刺激的效应功能中的相互依赖性。
Infect Immun. 2001 Oct;69(10):6064-73. doi: 10.1128/IAI.69.10.6064-6073.2001.
6
Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes.新型隐球菌的纯化荚膜多糖可诱导人单核细胞分泌白细胞介素-10。
Infect Immun. 1996 Jul;64(7):2846-9. doi: 10.1128/iai.64.7.2846-2849.1996.
7
Mechanisms of impaired anticryptococcal activity of monocytes from donors infected with human immunodeficiency virus.感染人类免疫缺陷病毒的供体单核细胞抗隐球菌活性受损的机制。
J Infect Dis. 1997 Aug;176(2):537-40. doi: 10.1086/517284.
8
Interleukin-12 counterbalances the deleterious effect of human immunodeficiency virus type 1 envelope glycoprotein gp120 on the immune response to Cryptococcus neoformans.
J Infect Dis. 2001 Jan 1;183(1):51-8. doi: 10.1086/317648. Epub 2000 Nov 21.
9
Role of capsule and interleukin-6 in long-term immune control of Cryptococcus neoformans infection by specifically activated human peripheral blood mononuclear cells.荚膜和白细胞介素-6在特异性激活的人外周血单个核细胞对新型隐球菌感染的长期免疫控制中的作用。
Infect Immun. 2006 Sep;74(9):5302-10. doi: 10.1128/IAI.00661-06.
10
Regulatory role of exogenous IL-10 in the development of immune response versus Cryptococcus neoformans.外源性白细胞介素-10在针对新型隐球菌的免疫反应发展中的调节作用。
Clin Exp Immunol. 1997 Aug;109(2):242-7. doi: 10.1046/j.1365-2249.1997.4021303.x.

引用本文的文献

1
Identification of IFN-γ-producing T cells as the main mediators of the side effects associated to mouse interleukin-15 sustained exposure.鉴定产生干扰素-γ的T细胞是与小鼠白细胞介素-15持续暴露相关副作用的主要介导因子。
Oncotarget. 2016 Aug 2;7(31):49008-49026. doi: 10.18632/oncotarget.10264.
2
Direct microbicidal activity of cytotoxic T-lymphocytes.细胞毒性T淋巴细胞的直接杀菌活性。
J Biomed Biotechnol. 2010;2010:249482. doi: 10.1155/2010/249482. Epub 2010 Jun 23.
3
Interleukin-15 increases vaccine efficacy through a mechanism linked to dendritic cell maturation and enhanced antibody titers.
白细胞介素-15通过与树突状细胞成熟和抗体滴度增强相关的机制提高疫苗效力。
Clin Vaccine Immunol. 2008 Jan;15(1):131-7. doi: 10.1128/CVI.00320-07. Epub 2007 Nov 28.
4
Induction of T helper type 1 responses by a polysaccharide deacetylase from Cryptococcus neoformans.新型隐球菌的一种多糖脱乙酰酶诱导1型辅助性T细胞应答
Infect Immun. 2003 Sep;71(9):5412-7. doi: 10.1128/IAI.71.9.5412-5417.2003.
5
Phagocytosis and protein processing are required for presentation of Cryptococcus neoformans mitogen to T lymphocytes.将新型隐球菌丝裂原呈递给T淋巴细胞需要吞噬作用和蛋白质加工。
Infect Immun. 2000 Nov;68(11):6147-53. doi: 10.1128/IAI.68.11.6147-6153.2000.
6
Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo.通过可变剪接产生的白细胞介素15 mRNA亚型在体内免疫反应中的不同作用。
J Exp Med. 2000 Jan 3;191(1):157-70. doi: 10.1084/jem.191.1.157.
7
The cell wall and membrane of Cryptococcus neoformans possess a mitogen for human T lymphocytes.新型隐球菌的细胞壁和细胞膜含有一种人类T淋巴细胞的促有丝分裂原。
Infect Immun. 1999 Feb;67(2):936-41. doi: 10.1128/IAI.67.2.936-941.1999.